COVID lockdowns impact assessment

What happened: Less than half of U.S. healthcare workers have received the updated COVID-19 vaccine, according to a CDC survey. Meanwhile, a UK COVID-19 inquiry found that lockdowns may have cost thousands of lives, highlighting the potential negative impacts of stringent pandemic measures. Deborah Birx, a key architect of U.S. COVID-19 response, was recently seen dismissing PCR testing for Hantavirus, raising questions about the accuracy of COVID-19 testing.

Market impact: Healthcare stocks and vaccine manufacturers may face pressure due to low uptake of updated COVID-19 vaccines among healthcare workers. Public health and biotechnology sectors could also be impacted by the ongoing debate surrounding the effectiveness and necessity of lockdowns. The revelation about Birx's stance on PCR testing could potentially erode public trust in COVID-19 testing methods and protocols.

What to watch next: Upcoming CDC reports on vaccine uptake among healthcare workers and other key populations. The release of the final UK COVID-19 inquiry report, which could provide more detailed insights into the impacts of lockdowns. U.S. public health officials' response to the Birx video and any potential changes in COVID-19 testing policies.